Prof. Ramesh Chandra
Professor Ramesh Chandra Professor Ramesh Chandra Professor Ramesh Chandra Professor Ramesh Chandra Professor Ramesh Chandra Professor Ramesh Chandra Professor Ramesh Chandra Professor Ramesh Chandra
Scroll Down

Prof. Ramesh Chandra

Ph.D, FAMS, FRSC (London)

Biomedical scientist, Educationist, Administrator, And Institution builder

Advancing chemotherapeutic and nanothermopetic approaches for kinder, gentler modalilites to improve, patient outcome and betterment of human health.

View Publications View Patents View Projects

About

Prof. Ramesh Chandra (born 01 July 1957) is a distinguished biomedical scientist, eminent educationist, efficient administrator and institution builder [1] who has worked mainly to address the urgent need to provide chemotherapeutic approaches and “kindler and gentle” chemotherapy modalities. He has authored more than 400 research publications and edited dozens of books. Moreover, he has mentored more than 100 Ph.D. students and a large number of M.Phil., M.Sc., M.Tech. and M.D. students, who are occupying high positions globally. Professor Chandra shows deep commitment to the cause of higher education & research and possess in ample measure quality of dynamic leadership, vision required for building academic institutions. Prof. Chandra is currently the Vice Chancellor of Maharaja Surajmal Brij University, Bharatpur, Rajasthan since March 2023 and the Founder Director of Institute of Nano Medical Sciences (INMS) at University of Delhi, Delhi, India. An outstanding Scientist and revered teacher, Prof. Chandra is the recipient of several professional national/ international recognitions: J. William Fulbright Scholarship (1993); The Rockefeller Foundation USA-Biotechnology Career Award (1993); Award of the Highest Honor of Soka University, Tokyo, Japan (2000); Millennium Plaques of Honor (Life Time Achievement Award for contribution in Science & Technology) by the Indian Science Congress Association (ISCA) {2017-2018}, Lifetime Achievement Award of Indian Academy of Biomedical Sciences (2022), Lifetime Achievement Award of the Indian Chemical Society (ICS) (2003); UGC Research Scientist Award (1988); UGC Career Award (1993); Rajib Goyal Award for Young Scientists (2002); Fellowship of: Indian Academy of Biomedical Sciences (IABS); International Academy of Physical Sciences; Institution of Chemists, India; Indian Chemical Society; National Academy of Medical Sciences (FAMS), Royal Society of Chemistry, London and others.

Key Positions Held

Administrative, Academic and Research positions held over the years

Vice-Chancellor

Maharaja Surajmal Brij University, Bharatpur, Rajasthan

March 2023 - Onwards

Founder Director

Dr. B.R. Ambedkar Center for Biomedical Research

University of Delhi, Delhi – 110007, INDIA

Founder Director

INSTITUTE OF NANO MEDICAL SCIENCES

University of Delhi, Delhi – 110007, INDIA

Senior Professor & Head

Department of Chemistry

University of Delhi, Delhi – 110007, INDIA

Vice-Chancellor (1999-2005)

Bundelkhand University

Jhansi - 284128, UP, INDIA

Member, Planning Commission (2002-2005)

Government of Uttar Pradesh

Lucknow - 226001, UP, INDIA

President

Indian Chemical Society (2003-2005)

92, Acharya Prafulla Chandra Road, Kolkata-700009, INDIA

View All Experience

Education

Degree Course University Year
Ph.D. Chemistry University of Delhi, Delhi 1982
F.IC Chemistry Institution of Chemists, India 1987
Diploma Forensic Science University of Delhi, Delhi 1979
M.Phil. Chemistry University of Delhi, Delhi 1978
M.Sc. Chemistry Meerut University, Meerut 1977

Research Focus

Therapeutic Innovations

Designing and evaluating chemotherapeutic strategies that prioritize efficacy with reduced toxicity.

Drug Delivery

Exploring delivery systems for targeted, patient-friendly chemotherapy interventions.

Translational Impact

Bridging laboratory discoveries with clinical applications for improved cancer care.

×

Therapeutic Innovations

Professor Chandra's research in therapeutic innovations focuses on developing novel chemotherapeutic approaches that maximize treatment efficacy while minimizing adverse effects on patients.

Key Research Areas:

  • Noscapine Analogues: Development of 9-chloro noscapine and its derivatives for treating drug-resistant cancers, including glioblastoma and melanoma.
  • Natural Product Modifications: Structural modifications of active principles from Ayurvedic plants such as Withania somnifera, Asparagus racemosus, and Papaver somniferum for enhanced therapeutic potential.
  • Cancer Treatment Strategies: Design and synthesis of compounds targeting multiple cancer pathways with reduced systemic toxicity.
  • Metal Complexes: Development of novel metal-based therapeutic agents with selective anti-cancer properties.

Impact:

These innovations have led to multiple patents and clinical applications, offering hope for more tolerable cancer treatments with improved patient outcomes.

×

Drug Delivery

Advanced drug delivery systems are central to Professor Chandra's research, focusing on targeted delivery mechanisms that enhance therapeutic efficacy while reducing side effects.

Key Research Areas:

  • Nanoparticle-Based Delivery: Development of Fe₃O₄@SiO₂@PDA@Ag core-shell nanoparticles and silver nanocrystals for targeted cancer therapy.
  • Polymer-Based Systems: Non-viral vectors using chitosan and PEI (polyethylenimine) for gene and siRNA delivery to mammalian cells.
  • Solid Lipid Nanoparticles: PEG-conjugated solid lipid nanoparticles for improved brain delivery and extended biological half-life of therapeutic agents.
  • Liposomal Formulations: Advanced liposomal drug carriers for enhanced bioavailability and targeted delivery to tumor sites.

Impact:

These delivery systems have demonstrated significantly improved drug biodistribution, cellular uptake, and therapeutic outcomes in preclinical studies.

×

Translational Impact

Professor Chandra's translational research bridges the gap between laboratory discoveries and real-world clinical applications, ensuring that scientific innovations reach patients who need them.

Key Research Areas:

  • Clinical Translation: Converting laboratory findings into viable clinical treatments, with multiple compounds advancing to pre-clinical and clinical evaluation stages.
  • Collaborative Research: Partnerships with institutions like Harvard Medical School, Cornell Medical Center, and MIT to accelerate bench-to-bedside translation.
  • Drug Development Pipeline: Systematic approach to drug discovery, optimization, formulation, and regulatory pathway navigation.
  • Biomedical Applications: Focus on practical applications that directly impact cancer care, including improved treatment protocols and patient management strategies.

Impact:

Through 8 patents and over 400 publications, Professor Chandra's work has influenced global cancer treatment approaches and inspired new generations of researchers to pursue translational biomedical science.

Patents

Innovative research translated into intellectual property protecting novel discoveries in drug development and therapeutics.

8 Patents

Including Indian, European, and International patents in cancer therapeutics and drug development.

Novel Compounds

Patented innovations in antilipidemic, antioxidant, and anticancer drug formulations.

Global Recognition

Patents granted across multiple jurisdictions including India, Europe, and USA.

View All Patents

Mentorship

100+
Ph.D. mentees
Hundreds
M.Phil., M.Sc., M.Tech., M.D.
Global
Leadership positions

Many mentees have progressed to leading roles in academia, industry, and healthcare worldwide.

View All Ph.D. Mentees

Recent News

Latest updates and announcements

Recent News

Contact

If you would like to collaborate or request the full list of publications, please reach out.

Office:
Institute of Nano Medical sciences (INMS)
University of Delhi
Delhi-110007, India

B-108, Department of Chemistry Building
University of Delhi,
Delhi - 110007, India